Bioanalytical Project Management — a Critical Function Adapted to the Study Type(s) of Your Drug Development Program
The objective of quantitative bioanalysis is to provide precise and accurate sample analysis results within the acceptable tolerance (variability), in line with the study scope, so that sponsors can make appropriate go/no-go decisions. For proactive and efficient study progression, stakeholders must fully understand the operational, logistical, technical, and scientific considerations for the bioanalytical phase of various study types within a drug development program. Webinar participants will receive insight on this framework and the relevant critical control points.
The objective of quantitative bioanalysis is to provide precise and accurate sample analysis results within the acceptable tolerance (variability) and study scope, so that sponsors can make go/no-go decisions.